Electrophysiology Market Projected to Reach USD 17 Billion by 2032

1
Electrophysiology Market Projected to Reach USD
17 Billion by 2032
2

• Industry Insights

• The Electrophysiology Market is expected to
  witness significant growth by 2032, driven by the
  rising prevalence of lifestyle-related health
  conditions. Sedentary habits, excessive alcohol
  consumption, and smoking have led to a marked
  increase in heart disease cases, further boosting
  the demand for electrophysiology (EP) tests.
• Aging is another key factor contributing to the
  growing healthcare burden, with conditions such
  as heart failure, bradycardia requiring cardiac
  pacing, atrial fibrillation, and ventricular
  arrhythmias post-myocardial infarction often
  necessitating EP testing.
• In the past decade, the healthcare sector has
  seen remarkable advancements in ablation
  technologies, with a strong focus on developing
  automated, single-shot solutions for treating
  cardiac arrhythmias. Innovations such as
  sophisticated 3D mapping techniques, along with
  the integration of AI and machine learning, are
  expected to enhance the diagnosis and treatment
  of cardiac diseases
• In July 2022, Stereotaxis applied for CE Marking
  for its MAGiC catheter, a magnetic interventional
  ablation catheter designed for minimally invasive
  procedures using robotic navigation. Similar
  robotics-based innovations in cardiac ablation
  procedures are being developed by leading players
  like GE Healthcare, Japan Lifeline, Medtronic,
  Siemens AG, and Abbott Laboratories, among others.

3

• The Electrophysiology Market is segmented based
  on product, indication, end-use, and region.
• By product, the market is divided into EP
  diagnostic catheters, EP ablation catheters, and
  EP laboratory devices. The EP ablation catheters
  segment generated more than USD 2.6 billion in
  revenue in 2022, driven by the growing geriatric
  population in developing countries, contributing
  to a larger patient base with chronic diseases,
  thus increasing the demand for EP ablation
  catheters.
• In terms of indication, the Electrophysiology
  Market share from atrial flutter is expected to
  surpass USD 1.7 billion by 2032. Atrial flutter,
  caused by disruptions in the hearts electrical
  system due to conditions like hypertension, is on
  the rise. According to the World Health
  Organization (WHO), hypertension cases among
  individuals aged 30-79 surged from 650 million to
  1.28 billion over the past 30 years.
• Regarding end-use, the market is segmented into
  hospitals, ambulatory surgery centers,
  catheterization/EP laboratories, and others.
  Ambulatory surgery centers accounted for over USD
  180 million in revenue in 2022, as patients
  increasingly favor these centers for single-day
  cardiovascular surgeries, given their access to
  advanced medical facilities and affordable,
  high-quality care.

4

• Regional Analysis

Regionally, the Asia Pacific Electrophysiology
Market is projected to exceed USD 3.9 billion by
2032. Increased public and private funding for
cardiovascular disease awareness initiatives,
coupled with the rapid growth of medical tourism
in countries such as China and India, is expected
to drive market expansion across the APAC region
during the forecast period.

• Competitive Analysis

• Abbott Laboratories
• Boston Scientific Corporation
• Biotronik SE Co KG
• GE Healthcare
• Johnson Johnson
• Japan Lifeline
• Koninklijke Philips N.V.
• Siemens Healthineers AG
• Medtronic plc.
• MicroPort Scientific Corporation

5
Biotechnology Instruments Market _at_
https//www.gminsights.com/industry-analysis/elect
rophysiology-market
Request for sample of this research report _at_
https//www.gminsights.com/request-sample/detail/2
968
Request for customization _at_ https//www.gminsights
.com/roc/2968
6
Stay In Touch Social Media
7
THANK YOU
www.gminsights.com